Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 138 entries
View as:

A Long-term Trial of OPC-34712 in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01456897 Org: User:
Start: 10/31/11 End: - Due: -

A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02994394 Org: User:
Start: 01/06/17 End: 02/28/17 Due: 02/28/18

A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01961882 Org: User:
Start: 10/31/13 End: 11/16/17 Due: 11/16/18

A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04182958 Org: User:
Start: 11/25/19 End: 12/19/19 Due: 12/19/20

Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT06036108 Org: User:
Start: 10/03/23 End: 04/08/25 Due: 04/08/26

Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00791999 Org: User:
Start: 11/30/08 End: 01/31/11 Due: 01/31/12

Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01074710 Org: User:
Start: 02/28/10 End: 05/31/10 Due: 05/31/11

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02105285 Org: User:
Start: 04/30/14 End: 01/31/15 Due: 01/31/16

A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration

Phase: N/A Priority: Normal
NCT ID: NCT02331680 Org: User:
Start: 12/31/14 End: 05/31/16 Due: 05/31/17

A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02085460 Org: User:
Start: 03/31/14 End: 08/31/15 Due: 08/31/16

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT02168920 Org: User:
Start: 06/11/14 End: 03/18/16 Due: 03/18/17

A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT05687071 Org: User:
Start: 02/27/23 End: 11/02/24 Due: 11/02/25

An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00463151 Org: User:
Start: 06/30/07 End: 08/31/08 Due: 08/31/09

A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01562743 Org: User:
Start: 08/31/08 End: 10/31/10 Due: 10/31/11

Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03303105 Org: User:
Start: 12/07/17 End: 06/16/20 Due: 06/16/21

A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg

Phase: N/A Priority: Normal
NCT ID: NCT01048788 Org: User:
Start: 12/31/09 End: 08/31/11 Due: 08/31/12

A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01801930 Org: User:
Start: 03/31/13 End: 01/31/15 Due: 01/31/16

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

Phase: N/A Priority: Normal
NCT ID: NCT03179787 Org: User:
Start: 04/01/17 End: 07/06/20 Due: 07/06/21

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Phase: N/A Priority: Normal
NCT ID: NCT04812379 Org: User:
Start: 04/07/21 End: 06/21/24 Due: 06/21/25

Dose-response Study of OPC-12759 Ophthalmic Suspension

Phase: N/A Priority: Normal
NCT ID: NCT00234078 Org: User:
Start: 01/31/05 End: 03/31/07 Due: 03/31/08

Safety Study of OPC-12759 Ophthalmic Solution

Phase: N/A Priority: Normal
NCT ID: NCT01471093 Org: User:
Start: 11/30/11 End: 02/29/12 Due: 02/28/13

Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence

Phase: N/A Priority: Normal
NCT ID: NCT04107051 Org: User:
Start: 10/01/19 End: 02/06/24 Due: 02/06/25

Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients

Phase: N/A Priority: Normal
NCT ID: NCT01439009 Org: User:
Start: 09/30/11 End: 03/31/14 Due: 03/31/15

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload

Phase: N/A Priority: Normal
NCT ID: NCT03255226 Org: User:
Start: 03/07/18 End: 07/15/21 Due: 07/15/22

Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT03906695 Org: User:
Start: 03/15/19 End: 01/31/26 Due: 01/31/27